MVA Investors, LLC, 10% Owner, Director at iTeos Therapeutics, Inc. (ITOS), sold 1,399,269 shares at $47.65 ($65.1M) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $65.1M ITOS by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.63 | 23,353 | $1.1M | 1.7% |
| 2 | $47.63 | 23,353 | $1.1M | 1.7% |
| 3 | $47.65 | 432,903 | $20.6M | 31.7% |
| 4 | $47.65 | 432,903 | $20.6M | 31.7% |
| 5 | $49.37 | 39,481 | $1.9M | 3.0% |
| 6 | $49.37 | 1,682 |
| $83K |
| 0.1% |
| 7 | $49.37 | 1,682 | $83K | 0.1% |
| 8 | $49.37 | 39,481 | $1.9M | 3.0% |
| 9 | $50.63 | 17,173 | $869K | 1.3% |
| 10 | $50.63 | 731 | $37K | 0.1% |
| 11 | $50.63 | 17,173 | $869K | 1.3% |
| 12 | $41.84 | 88,054 | $3.7M | 5.7% |
| 13 | $41.84 | 29,623 | $1.2M | 1.9% |
| 14 | $41.84 | 29,623 | $1.2M | 1.9% |
| 15 | $41.84 | 88,054 | $3.7M | 5.7% |
| 16 | $43.36 | 3,138 | $136K | 0.2% |
| 17 | $43.36 | 9,366 | $406K | 0.6% |
| 18 | $43.36 | 3,138 | $136K | 0.2% |
| 19 | $43.36 | 9,366 | $406K | 0.6% |
| 20 | $44.44 | 33,297 | $1.5M | 2.3% |
| 21 | $44.44 | 11,199 | $498K | 0.8% |
| 22 | $44.44 | 11,199 | $498K | 0.8% |
| 23 | $44.44 | 33,297 | $1.5M | 2.3% |
| 24 | $45.48 | 7,483 | $340K | 0.5% |
| 25 | $45.48 | 2,517 | $114K | 0.2% |
| 26 | $45.48 | 7,483 | $340K | 0.5% |
| 27 | $45.48 | 2,517 | $114K | 0.2% |
| Total | $46.54 avg | 1,399,269 | $65.1M | 100% |
| Filing → |
| TNGX | SELL | 2024-05-03 | $1.6M | — | Filing → |
| TNGX | SELL | 2023-10-11 | $2.2M | — | Filing → |
| TNGX | BUY | 2023-08-15 | $2.4M | — | Filing → |